Difficult Decisions in Endocrine Surgery : An Evidence-Based Approach (Difficult Decisions in Surgery: An Evidence-based Approach) (2ND)

個数:
  • 予約

Difficult Decisions in Endocrine Surgery : An Evidence-Based Approach (Difficult Decisions in Surgery: An Evidence-based Approach) (2ND)

  • 現在予約受付中です。出版後の入荷・発送となります。
    重要:表示されている発売日は予定となり、発売が延期、中止、生産限定品で商品確保ができないなどの理由により、ご注文をお取消しさせていただく場合がございます。予めご了承ください。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Hardcover:ハードカバー版
  • 言語 ENG
  • 商品コード 9783032052872

Full Description

Following a successful first edition in 2018, this book offers predominantly new chapters reflecting the advances made in the field. This second edition keeps the recommendations based on newly published data. Many new chapter authors are also on board making this book a comprehensive overview of difficult decisions encountered within endocrine surgery. Brief uniformly formatted chapters are devoted to answering specific questions relevant to a range of topics across endocrine surgery based upon detailed analysis of available evidence.

Difficult Decisions in Endocrine Surgery: An Evidence-Based Approach features a wealth of information on ideal approaches for making clinical decisions in selected clinical situations. It is an important and timely resource for all endocrine surgical trainees, fellows, practitioners, educators, and healthcare providers involved in the management of these patients.

Contents

Introductory Materials.- - Evidence-Based Medicine and the GRADE Approach.- - Clinical Decision Analysis.- - Decision making for surgical intervention in thyroid cancer.- - Involving Patients in Difficult Decisions About Having Surgery.- - Thyroid.- Familial Nonmedullary Thyroid Carcinoma: Definition, Genetics and Screening Challenges.- Operative management versus observation for thyroid nodules >4 cm with benign cytology.- Primary Repair Versus No Repair for Transected Recurrent Laryngeal Nerve.- Surgery Versus Active Surveillance for Papillary Thyroid Microcarcinoma.- Targeted Therapies in Conjunction with Surgery for Aggressive Thyroid Cancers.- Same-Day Versus Overnight Inpatient Surgery for Total Thyroidectomy.- Prophylactic Versus Selective Central Neck Dissection in Pediatric Papillary Thyroid Cancer.- Can surgery be safely delayed for low-risk papillary thyroid cancer?.- Can genetic testing be used to guide the extent of initial surgical intervention for papillary thyroid cancer?.- Quality of life in thyroid lobectomy versus total thyroidectomy.- Thyroid tissue in lymph nodes: Lateral aberrant thyroid versus metastatic thyroid carcinoma?.- Continued surveillance vs.-  no surveillance after resection of NIFTP.-

Thermal Ablation of Thyroid Neoplasms.- Lobectomy Versus Total Thyroidectomy For Low-Risk Pediatric Papillary Thyroid Carcinoma.- Parathyroid.- Four Gland Exploration versus Four Dimensional Computed Tomography in Patients with Nonlocalized Primary Hyperparathyroidism.- Is intraoperative parathyroid hormone (IOPTH) monitoring necessary in the setting of evolving imaging?.- Lymph Node Dissection versus No Lymph Node Dissection for Parathyroid Cancer.- Early Versus Late Parathyroidectomy for Tertiary (Posttransplant) Hyperparathyroidism.- Observation versus Surgery for Pregnant Patients with Primary Hyperparathyroidism.- "Normocalcemic Hyperparathyroidism: Surgical Intervention vs.- Continued Observation".- Adrenal.- Lateral Transabdominal Adrenalectomy versus Posterior Retroperitoneal Adrenalectomy.- Bilateral Adrenalectomy Versus Medical Management for Cushing's Syndrome with Bilateral Adrenal Hyperplasia.- Routine versus Selective Screening for Primary Aldosteronism in Patients with Hypertension.- Optimal Preoperative Management for Pheochromocytoma.- Post-Delivery vs.- Immediate Resection of Pheochromocytoma During Pregnancy.- Diagnosis, Management, and Outcomes of Metastases to the Adrenal Gland.- Pancreas.- Surgery Versus Observation for Asymptomatic Nonfunctioning Pancreatic Neuroendocrine Tumors.- Medical management vs.- surgical exploration for non-localized insulinomas.- Resection of Primary Tumor versus Observation in Metastatic Small Bowel Neuroendocrine Tumor with Unresectable Distant Disease.- Resection Versus Observation in Patients with Gastrinoma and MEN-1.- Routine Octreotide Versus No Octreotide for Metastatic Neuroendocrine Tumors with Intraoperative Carcinoid Crisis.

最近チェックした商品